Clinical Trial Update: The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease

View source ↗

Summary

This trial studied the vitreous proteome and inflammatory mediators in ocular inflammatory disease, including uveitis and vasculitis, and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Inflammatory Disease
• Uveitis
• Vasculitis

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Uveitis, Vasculitis | Status: COMPLETED